You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage

https://doi.org/10.1136/jnnp.2010.206417

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Linked articles 198994.

    • Funding University of Lille.

    • Competing interests DL has had consultancy roles for and has contributed to advisory boards, steering committees, and adjudication committees for Sanofi–Aventis, Servier, Boehringer Ingelheim, AstraZeneca and Novo Nordisk, fees for which were paid towards research at ADRINORD (Association pour le Développement de la Recherche et de l'Innovation dans le Nord-Pas de Calais) or the research account of the hospital (délégation à la recherche du CHU de Lille). He was reimbursed for travel or accommodation expenses needed for the participation on these boards and committees. CC has participated in the BOREALIS trial (Sanofi–Aventis), fees for which were paid towards research at ADRINORD (Association pour le Développement de la Recherche et de l'Innovation dans le Nord-Pas de Calais). She was reimbursed for travel or accommodation and expenses needed for investigator meetings.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles